Insider Transactions in Q1 2022 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 20
2022
|
A J Kazimi Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,205
-0.64%
|
$74,410
$2.74 P/Share
|
Mar 20
2022
|
James L Herman VP and Chief Compliance Office |
SELL
Payment of exercise price or tax liability
|
Direct |
1,280
-3.05%
|
$2,560
$2.74 P/Share
|
Mar 17
2022
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
SELL
Other acquisition or disposition
|
Direct |
15,000
-8.4%
|
$30,000
$2.74 P/Share
|
Mar 16
2022
|
A J Kazimi Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+0.34%
|
$40,000
$2.59 P/Share
|
Mar 16
2022
|
Joseph C Galante |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+2.17%
|
$2,000
$2.59 P/Share
|
Mar 16
2022
|
John M. Hamm VP Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+42.74%
|
$40,000
$2.59 P/Share
|
Mar 16
2022
|
Joey A Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.61%
|
$10,000
$2.59 P/Share
|
Mar 16
2022
|
James Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+4.68%
|
$2,000
$2.59 P/Share
|
Mar 16
2022
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.54%
|
$2,000
$2.59 P/Share
|
Mar 16
2022
|
Caroline Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+5.96%
|
$2,000
$2.59 P/Share
|